The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2020Evaluation of ANAVEX2-73 (blarcamesine) in Participants with Parkinson’s Disease
Study Rationale:
We are testing ANAVEX2-73 (also known as blarcamesine), which previous research has shown helps improve behaviors as well as normalizes biochemical changes in a Parkinson’s... -
, 2020The Role of USP30 in Idiopathic Parkinson’s Disease
Study Rationale:
Dopamine neurons are highly vulnerable to age-dependent increases in mitochondrial dysfunction, oxidative stress, and protein accumulation due to their high metabolic activity... -
Research Grant, 2020Biomarker for Mitophagy Pathway Activation
Study Rationale:
Abnormal PINK1-PRKN directed mitochondrial quality control appears to be an important contributor to Parkinson’s disease (PD). Measures to assess activation of this pathway in... -
Research Grant Supplement, 2020Developing Biosignatures for Parkinson's Disease Using Sense of Smell (Supplement)
Study Rationale:
It has been described that people with Parkinson’s disease have a specific signature odor. This odor arises from an oily skin secretion called sebum. Odor detection in the nose is... -
The Role of Inflammation in Parkinson's Disease, 2020The Role of Viral Infection in Immune Dysregulation of Cells in Parkinson’s
Study Rationale:
It has been observed that immune cells from Parkinson’s disease (PD) blood respond to pathogens in a way that promotes inflammation. However, it is unknown whether this... -
Priority Biology, 2020Structural Insights into Activated Intermediates of Parkin Continued
Study Rationale:
Loss of proteins responsible for removing damaged mitochondria (the cell power plants) is the most common cause of young-onset Parkinson’s disease (YOPD). Parkin and PINK1 are key...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.